{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:02:30Z","timestamp":1793289750835,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T00:00:00Z","timestamp":1770249600000},"content-version":"am","delay-in-days":369,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008907","name":"Oklahoma Medical Research Foundation","doi-asserted-by":"publisher","award":["06-12"],"award-info":[{"award-number":["06-12"]}],"id":[{"id":"10.13039\/100008907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008907","name":"Oklahoma Medical Research Foundation","doi-asserted-by":"publisher","award":["95-12"],"award-info":[{"award-number":["95-12"]}],"id":[{"id":"10.13039\/100008907","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","award":["10-001489"],"award-info":[{"award-number":["10-001489"]}],"id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012615","name":"University of Texas Health Science Center at Houston","doi-asserted-by":"publisher","award":["HSC-MS-08-0578"],"award-info":[{"award-number":["HSC-MS-08-0578"]}],"id":[{"id":"10.13039\/100012615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01 AR081280"],"award-info":[{"award-number":["R01 AR081280"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019921","name":"National Scleroderma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21 AR081933-01A1"],"award-info":[{"award-number":["R21 AR081933-01A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001844","name":"Scleroderma Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"publisher","award":["Pro00049290"],"award-info":[{"award-number":["Pro00049290"]}],"id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1136\/ard-2024-226034","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T02:30:22Z","timestamp":1726713022000},"page":"294-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3132-9200","authenticated-orcid":false,"given":"Xinran","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7655-2635","authenticated-orcid":false,"given":"Xiaodong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi L.","family":"Helke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Jacobs Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Guthridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9574-7355","authenticated-orcid":false,"given":"Judith A.","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-9978","authenticated-orcid":false,"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-6407","authenticated-orcid":false,"given":"Carol","family":"Feghali-Bostwick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8563-2036","authenticated-orcid":false,"given":"Lingyun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7938-5975","authenticated-orcid":false,"given":"Betty P.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard-2024-226034_bib1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2017.05.004","article-title":"Unfolding the pathogenesis of scleroderma through genomics and epigenomics","volume":"83","author":"Tsou","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1136\/ard-2024-226034_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12760-y","article-title":"GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways","volume":"10","author":"L\u00f3pez-Isac","year":"2019","journal-title":"Nat Commun"},{"key":"10.1136\/ard-2024-226034_bib3","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1136\/annrheumdis-2015-208154","article-title":"Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway","volume":"75","author":"L\u00f3pez-Isac","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2024-226034_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ng.3782","article-title":"A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases","volume":"49","author":"Zhao","year":"2017","journal-title":"Nat Genet"},{"key":"10.1136\/ard-2024-226034_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/annrheumdis-2021-220793","article-title":"Human SLE variant NCF1-R90H promotes kidney damage and murine lupus through enhanced Tfh2 responses induced by defective efferocytosis of macrophages","volume":"81","author":"Geng","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153619","article-title":"The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells","volume":"132","author":"Meng","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1136\/ard-2024-226034_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.164875","article-title":"NCF1-dependent production of ROS protects against lupus by regulating plasmacytoid dendritic cell development and functions","volume":"8","author":"Luo","year":"2023","journal-title":"JCI Insight"},{"key":"10.1136\/ard-2024-226034_bib9","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230774","article-title":"NADPH oxidase exerts a B cell-intrinsic contribution to lupus risk by modulating endosomal TLR signals","volume":"221","author":"Liu","year":"2024","journal-title":"J Exp Med"},{"key":"10.1136\/ard-2024-226034_bib10","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","article-title":"The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis","volume":"75","author":"Brkic","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2018.31","article-title":"Type I interferon in rheumatic diseases","volume":"14","author":"Muskardin","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib12","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib13","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1136\/annrheumdis-2017-211448","article-title":"Mapping and predicting mortality from systemic sclerosis","volume":"76","author":"Elhai","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib14","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972-2002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179917","article-title":"Optimization of a murine and human tissue model to recapitulate dermal and pulmonary features of systemic sclerosis","volume":"12","author":"Watanabe","year":"2017","journal-title":"PLoS One"},{"key":"10.1136\/ard-2024-226034_bib16","doi-asserted-by":"crossref","first-page":"L736","DOI":"10.1152\/ajplung.00210.2013","article-title":"Bleomycin delivery by osmotic minipump: similarity to human scleroderma interstitial lung disease","volume":"306","author":"Lee","year":"2014","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1136\/ard-2024-226034_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/BOR.0000000000000331","article-title":"Animal models of scleroderma: recent progress","volume":"28","author":"Marangoni","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib18","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard-2024-226034_bib19","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2144\/000112729","article-title":"Standardized quantification of pulmonary fibrosis in histological samples","volume":"44","author":"H\u00fcbner","year":"2008","journal-title":"Biotechniques"},{"key":"10.1136\/ard-2024-226034_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.739358","article-title":"Macrophage-Related SPP1 as a Potential Biomarker for Early Lymph Node Metastasis in Lung Adenocarcinoma","volume":"9","author":"Dong","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1136\/ard-2024-226034_bib21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/CCM.0b013e31822f09d7","article-title":"Mechanical stress induces lung fibrosis by epithelial-mesenchymal transition","volume":"40","author":"Cabrera-Ben\u00edtez","year":"2012","journal-title":"Crit Care Med"},{"key":"10.1136\/ard-2024-226034_bib22","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/1541-7786.MCR-14-0105","article-title":"TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells","volume":"12","author":"D'Angelo","year":"2014","journal-title":"Mol Cancer Res"},{"key":"10.1136\/ard-2024-226034_bib23","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1164\/rccm.201010-1719OC","article-title":"Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis","volume":"184","author":"Gibbons","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1136\/ard-2024-226034_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112131","article-title":"Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner","volume":"42","author":"Hoeft","year":"2023","journal-title":"Cell Rep"},{"key":"10.1136\/ard-2024-226034_bib25","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.4049\/jimmunol.1200604","article-title":"Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury","volume":"190","author":"Osterholzer","year":"2013","journal-title":"J Immunol"},{"key":"10.1136\/ard-2024-226034_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52920-0","article-title":"Association of NCF1 polymorphism with systemic lupus erythematosus and systemic sclerosis but not with ANCA-associated vasculitis in a Japanese population","volume":"9","author":"Yokoyama","year":"2019","journal-title":"Sci Rep"},{"key":"10.1136\/ard-2024-226034_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/labinvest.2014.145","article-title":"A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis","volume":"95","author":"Liang","year":"2015","journal-title":"Lab Invest"},{"key":"10.1136\/ard-2024-226034_bib28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/annrheumdis-2019-215820","article-title":"NCF1-339 polymorphism is associated with altered formation of neutrophil extracellular traps, high serum interferon activity and antiphospholipid syndrome in systemic lupus erythematosus","volume":"79","author":"Linge","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib29","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/annrheumdis-2017-211287","article-title":"A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus","volume":"76","author":"Olsson","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib30","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13073-017-0417-1","article-title":"A novel multi-network approach reveals tissue-specific cellular modulators of fibrosis in systemic sclerosis","volume":"9","author":"Taroni","year":"2017","journal-title":"Genome Med"},{"key":"10.1136\/ard-2024-226034_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02441-2018","article-title":"Proliferating SPP1\/MERTK-expressing macrophages in idiopathic pulmonary fibrosis","volume":"54","author":"Morse","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1136\/ard-2024-226034_bib32","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/art.38288","article-title":"Association of Interferon- and transforming growth factor \u03b2-regulated genes and macrophage activation with systemic sclerosis-related progressive lung fibrosis","volume":"66","author":"Christmann","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib33","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1016\/j.cell.2024.05.015","article-title":"Immune mechanisms in fibrotic interstitial lung disease","volume":"187","author":"Kamiya","year":"2024","journal-title":"Cell"},{"key":"10.1136\/ard-2024-226034_bib34","article-title":"Osteopontin Links Myeloid Activation and Disease Progression in Systemic Sclerosis","volume":"1","author":"Gao","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1136\/ard-2024-226034_bib35","article-title":"An interleukin 6 responsive plasma cell signature is associated with disease progression in systemic sclerosis interstitial lung disease","volume":"26","author":"Jia","year":"2023","journal-title":"i Sci"},{"key":"10.1136\/ard-2024-226034_bib36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.595811","article-title":"Disparate Interferon Signaling and Shared Aberrant Basaloid Cells in Single-Cell Profiling of Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease","volume":"12","author":"Valenzi","year":"2021","journal-title":"Front Immunol"},{"key":"10.1136\/ard-2024-226034_bib37","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1186\/s12967-023-04279-0","article-title":"Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis","volume":"21","author":"Ji","year":"2023","journal-title":"J Transl Med"},{"key":"10.1136\/ard-2024-226034_bib38","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1136\/ard.2006.067967","article-title":"Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?","volume":"67","author":"Carulli","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib39","first-page":"S44","article-title":"CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment","volume":"30","author":"Bandinelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib40","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1002\/art.40171","article-title":"CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts","volume":"69","author":"Wu","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib41","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.jid.2018.01.006","article-title":"Mycophenolate Mofetil Treatment of Systemic Sclerosis Reduces Myeloid Cell Numbers and Attenuates the Inflammatory Gene Signature in Skin","volume":"138","author":"Hinchcliff","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1136\/ard-2024-226034_bib42","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1136\/annrheumdis-2021-220280","article-title":"Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid","volume":"80","author":"Yager","year":"2021","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib43","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.yexcr.2017.08.028","article-title":"Upregulation of PD-L1 by SPP1 mediates macrophage polarization and facilitates immune escape in lung adenocarcinoma","volume":"359","author":"Zhang","year":"2017","journal-title":"Exp Cell Res"},{"key":"10.1136\/ard-2024-226034_bib44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.pccm.2023.05.002","article-title":"TIMP-1 and its potential diagnostic and prognostic value in pulmonary diseases","volume":"1","author":"Almuntashiri","year":"2023","journal-title":"Chin Med J Pulm Crit Care Med"},{"key":"10.1136\/ard-2024-226034_bib45","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/annrheumdis-2012-201958","article-title":"Toll-like receptor-mediated, enhanced production of profibrotic TIMP-1 in monocytes from patients with systemic sclerosis: role of serum factors","volume":"72","author":"Ciechomska","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib46","first-page":"221","article-title":"The association of serum matrix metalloproteinases and their tissue inhibitor levels with scleroderma disease severity","volume":"20","author":"Toubi","year":"2002","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard-2024-226034_bib47","first-page":"683","article-title":"Effect of chloroquine phosphate treatment on serum MMP-9 and TIMP-1 levels in patients with systemic lupus erythematosus","volume":"19","author":"Lesiak","year":"2010","journal-title":"Lupus (Los Angel)"},{"key":"10.1136\/ard-2024-226034_bib48","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00296-009-1135-9","article-title":"Relationships between MMP-2, MMP-9, TIMP-1 and TIMP-2 levels and their pathogenesis in patients with lupus nephritis","volume":"30","author":"Jiang","year":"2010","journal-title":"Rheumatol Int"},{"key":"10.1136\/ard-2024-226034_bib49","first-page":"261","article-title":"Expression of the matrix metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 in systemic lupus erythematosus patients","volume":"78","author":"Vira","year":"2020","journal-title":"Neth J Med"},{"key":"10.1136\/ard-2024-226034_bib50","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/annrheumdis-2017-212454","article-title":"Changes in macrophage transcriptome associate with systemic sclerosis and mediate GSDMA contribution to disease risk","volume":"77","author":"Moreno-Moral","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard-2024-226034_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s12931-018-0891-z","article-title":"A circulating cell population showing both M1 and M2 monocyte\/macrophage surface markers characterizes systemic sclerosis patients with lung involvement","volume":"19","author":"Trombetta","year":"2018","journal-title":"Respir Res"},{"key":"10.1136\/ard-2024-226034_bib52","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00018-022-04501-0","article-title":"Two major genes associated with autoimmune arthritis, Ncf1 and Fcgr2b, additively protect mice by strengthening T cell tolerance","volume":"79","author":"Li","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1136\/ard-2024-226034_bib53","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13075-016-0989-y","article-title":"CD163+ M2c-like macrophages predominate in renal biopsies from patients with lupus nephritis","volume":"18","author":"Olmes","year":"2016","journal-title":"Arthritis Res Ther"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724005697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724005697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard-2024-226034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:33:41Z","timestamp":1762086821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724005697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":53,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0003496724005697"],"URL":"https:\/\/doi.org\/10.1136\/ard-2024-226034","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human hypofunctional NCF1 variants promote pulmonary fibrosis in the bleomycin-induced mouse model and patients with systemic sclerosis via expansion of SPP1+ monocytes-derived macrophages","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard-2024-226034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}